nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Dysphonia—Sorafenib—liver cancer	0.022	0.034	CcSEcCtD
Flumazenil—Mood swings—Sorafenib—liver cancer	0.0124	0.0192	CcSEcCtD
Flumazenil—Redness—Epirubicin—liver cancer	0.00989	0.0153	CcSEcCtD
Flumazenil—Hyperventilation—Epirubicin—liver cancer	0.0097	0.015	CcSEcCtD
Flumazenil—Redness—Doxorubicin—liver cancer	0.00915	0.0142	CcSEcCtD
Flumazenil—Hyperventilation—Doxorubicin—liver cancer	0.00898	0.0139	CcSEcCtD
Flumazenil—Scotoma—Epirubicin—liver cancer	0.00879	0.0136	CcSEcCtD
Flumazenil—Tinnitus—Sorafenib—liver cancer	0.00846	0.0131	CcSEcCtD
Flumazenil—Flushing—Sorafenib—liver cancer	0.00842	0.013	CcSEcCtD
Flumazenil—Rigors—Epirubicin—liver cancer	0.00818	0.0126	CcSEcCtD
Flumazenil—Injection site pain—Epirubicin—liver cancer	0.00818	0.0126	CcSEcCtD
Flumazenil—Scotoma—Doxorubicin—liver cancer	0.00814	0.0126	CcSEcCtD
Flumazenil—Dysphonia—Epirubicin—liver cancer	0.00812	0.0125	CcSEcCtD
Flumazenil—Arrhythmia—Sorafenib—liver cancer	0.0081	0.0125	CcSEcCtD
Flumazenil—Erythema—Sorafenib—liver cancer	0.0079	0.0122	CcSEcCtD
Flumazenil—Delirium—Epirubicin—liver cancer	0.00776	0.012	CcSEcCtD
Flumazenil—Vasodilation—Epirubicin—liver cancer	0.0076	0.0118	CcSEcCtD
Flumazenil—Vasodilation procedure—Epirubicin—liver cancer	0.0076	0.0118	CcSEcCtD
Flumazenil—Injection site pain—Doxorubicin—liver cancer	0.00757	0.0117	CcSEcCtD
Flumazenil—Rigors—Doxorubicin—liver cancer	0.00757	0.0117	CcSEcCtD
Flumazenil—Dysphonia—Doxorubicin—liver cancer	0.00751	0.0116	CcSEcCtD
Flumazenil—Ventricular extrasystoles—Epirubicin—liver cancer	0.00739	0.0114	CcSEcCtD
Flumazenil—Delirium—Doxorubicin—liver cancer	0.00718	0.0111	CcSEcCtD
Flumazenil—Vasodilation procedure—Doxorubicin—liver cancer	0.00703	0.0109	CcSEcCtD
Flumazenil—Vasodilation—Doxorubicin—liver cancer	0.00703	0.0109	CcSEcCtD
Flumazenil—Cough—Sorafenib—liver cancer	0.00689	0.0107	CcSEcCtD
Flumazenil—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00684	0.0106	CcSEcCtD
Flumazenil—Hypertension—Sorafenib—liver cancer	0.00682	0.0105	CcSEcCtD
Flumazenil—Ventricular tachycardia—Epirubicin—liver cancer	0.00668	0.0103	CcSEcCtD
Flumazenil—Hiccups—Epirubicin—liver cancer	0.00668	0.0103	CcSEcCtD
Flumazenil—Injection site reaction—Epirubicin—liver cancer	0.00664	0.0103	CcSEcCtD
Flumazenil—Dry mouth—Sorafenib—liver cancer	0.00658	0.0102	CcSEcCtD
Flumazenil—Salivary hypersecretion—Epirubicin—liver cancer	0.00648	0.01	CcSEcCtD
Flumazenil—Hiccups—Doxorubicin—liver cancer	0.00618	0.00955	CcSEcCtD
Flumazenil—Ventricular tachycardia—Doxorubicin—liver cancer	0.00618	0.00955	CcSEcCtD
Flumazenil—Injection site reaction—Doxorubicin—liver cancer	0.00614	0.0095	CcSEcCtD
Flumazenil—Salivary hypersecretion—Doxorubicin—liver cancer	0.006	0.00928	CcSEcCtD
Flumazenil—Abnormal vision—Epirubicin—liver cancer	0.00582	0.009	CcSEcCtD
Flumazenil—Dyspnoea—Sorafenib—liver cancer	0.00575	0.00889	CcSEcCtD
Flumazenil—Thrombophlebitis—Epirubicin—liver cancer	0.0056	0.00866	CcSEcCtD
Flumazenil—Fatigue—Sorafenib—liver cancer	0.00556	0.00859	CcSEcCtD
Flumazenil—Pain—Sorafenib—liver cancer	0.00551	0.00852	CcSEcCtD
Flumazenil—Abnormal vision—Doxorubicin—liver cancer	0.00539	0.00833	CcSEcCtD
Flumazenil—Hot flush—Epirubicin—liver cancer	0.00518	0.00801	CcSEcCtD
Flumazenil—Thrombophlebitis—Doxorubicin—liver cancer	0.00518	0.00801	CcSEcCtD
Flumazenil—Menopausal symptoms—Epirubicin—liver cancer	0.00514	0.00794	CcSEcCtD
Flumazenil—Urticaria—Sorafenib—liver cancer	0.00512	0.00792	CcSEcCtD
Flumazenil—Diplopia—Epirubicin—liver cancer	0.00485	0.00749	CcSEcCtD
Flumazenil—Hot flush—Doxorubicin—liver cancer	0.00479	0.00741	CcSEcCtD
Flumazenil—Affect lability—Epirubicin—liver cancer	0.00477	0.00738	CcSEcCtD
Flumazenil—Menopausal symptoms—Doxorubicin—liver cancer	0.00475	0.00735	CcSEcCtD
Flumazenil—Hypersensitivity—Sorafenib—liver cancer	0.00475	0.00734	CcSEcCtD
Flumazenil—Asthenia—Sorafenib—liver cancer	0.00462	0.00715	CcSEcCtD
Flumazenil—Mood swings—Epirubicin—liver cancer	0.00459	0.0071	CcSEcCtD
Flumazenil—GABRA6—Orphan transporters—NR1H4—liver cancer	0.00457	0.0129	CbGpPWpGaD
Flumazenil—Pruritus—Sorafenib—liver cancer	0.00456	0.00705	CcSEcCtD
Flumazenil—Ataxia—Epirubicin—liver cancer	0.00456	0.00705	CcSEcCtD
Flumazenil—GABRA4—Orphan transporters—NR1H4—liver cancer	0.00451	0.0128	CbGpPWpGaD
Flumazenil—Diplopia—Doxorubicin—liver cancer	0.00448	0.00693	CcSEcCtD
Flumazenil—Affect lability—Doxorubicin—liver cancer	0.00441	0.00683	CcSEcCtD
Flumazenil—Dizziness—Sorafenib—liver cancer	0.00426	0.00659	CcSEcCtD
Flumazenil—Mood swings—Doxorubicin—liver cancer	0.00425	0.00657	CcSEcCtD
Flumazenil—GABRA5—Orphan transporters—ANXA2—liver cancer	0.00424	0.012	CbGpPWpGaD
Flumazenil—Ataxia—Doxorubicin—liver cancer	0.00422	0.00652	CcSEcCtD
Flumazenil—GABRA3—Orphan transporters—ANXA2—liver cancer	0.00416	0.0118	CbGpPWpGaD
Flumazenil—Vomiting—Sorafenib—liver cancer	0.0041	0.00634	CcSEcCtD
Flumazenil—GABRA2—Orphan transporters—ANXA2—liver cancer	0.00409	0.0116	CbGpPWpGaD
Flumazenil—Rash—Sorafenib—liver cancer	0.00406	0.00628	CcSEcCtD
Flumazenil—GABRB3—Orphan transporters—ANXA2—liver cancer	0.00406	0.0115	CbGpPWpGaD
Flumazenil—Dermatitis—Sorafenib—liver cancer	0.00406	0.00628	CcSEcCtD
Flumazenil—Headache—Sorafenib—liver cancer	0.00404	0.00624	CcSEcCtD
Flumazenil—GABRA5—Orphan transporters—NR1H4—liver cancer	0.00401	0.0113	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—ANXA2—liver cancer	0.00399	0.0113	CbGpPWpGaD
Flumazenil—GABRA3—Orphan transporters—NR1H4—liver cancer	0.00393	0.0111	CbGpPWpGaD
Flumazenil—GABRA2—Orphan transporters—NR1H4—liver cancer	0.00387	0.0109	CbGpPWpGaD
Flumazenil—GABRB3—Orphan transporters—NR1H4—liver cancer	0.00384	0.0109	CbGpPWpGaD
Flumazenil—Nausea—Sorafenib—liver cancer	0.00383	0.00592	CcSEcCtD
Flumazenil—GABRG2—Orphan transporters—NR1H4—liver cancer	0.00377	0.0107	CbGpPWpGaD
Flumazenil—Drowsiness—Epirubicin—liver cancer	0.00373	0.00578	CcSEcCtD
Flumazenil—Sweating—Epirubicin—liver cancer	0.00358	0.00554	CcSEcCtD
Flumazenil—GABRA1—Orphan transporters—ANXA2—liver cancer	0.00349	0.00987	CbGpPWpGaD
Flumazenil—Drowsiness—Doxorubicin—liver cancer	0.00346	0.00534	CcSEcCtD
Flumazenil—Bradycardia—Epirubicin—liver cancer	0.00341	0.00528	CcSEcCtD
Flumazenil—GABRA6—Ion channel transport—ATP7B—liver cancer	0.00339	0.00959	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—ATP7B—liver cancer	0.00334	0.00947	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—SHC3—liver cancer	0.00334	0.00946	CbGpPWpGaD
Flumazenil—Hypoaesthesia—Epirubicin—liver cancer	0.00334	0.00516	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—liver cancer	0.00331	0.00512	CcSEcCtD
Flumazenil—GABRA1—Orphan transporters—NR1H4—liver cancer	0.0033	0.00933	CbGpPWpGaD
Flumazenil—Visual impairment—Epirubicin—liver cancer	0.00323	0.005	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—liver cancer	0.00316	0.00488	CcSEcCtD
Flumazenil—Tinnitus—Epirubicin—liver cancer	0.00313	0.00483	CcSEcCtD
Flumazenil—Flushing—Epirubicin—liver cancer	0.00311	0.00481	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—liver cancer	0.00309	0.00477	CcSEcCtD
Flumazenil—Chills—Epirubicin—liver cancer	0.00301	0.00465	CcSEcCtD
Flumazenil—Arrhythmia—Epirubicin—liver cancer	0.003	0.00463	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—liver cancer	0.00299	0.00462	CcSEcCtD
Flumazenil—GABRA5—Ion channel transport—ATP7B—liver cancer	0.00297	0.00841	CbGpPWpGaD
Flumazenil—Erythema—Epirubicin—liver cancer	0.00292	0.00451	CcSEcCtD
Flumazenil—GABRA3—Ion channel transport—ATP7B—liver cancer	0.00292	0.00826	CbGpPWpGaD
Flumazenil—Tinnitus—Doxorubicin—liver cancer	0.00289	0.00447	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—liver cancer	0.00288	0.00445	CcSEcCtD
Flumazenil—GABRA2—Ion channel transport—ATP7B—liver cancer	0.00287	0.00812	CbGpPWpGaD
Flumazenil—Tension—Epirubicin—liver cancer	0.00286	0.00443	CcSEcCtD
Flumazenil—GABRB3—Ion channel transport—ATP7B—liver cancer	0.00285	0.00806	CbGpPWpGaD
Flumazenil—Nervousness—Epirubicin—liver cancer	0.00283	0.00438	CcSEcCtD
Flumazenil—GABRA6—Transmission across Chemical Synapses—GLUL—liver cancer	0.00281	0.00794	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—ATP7B—liver cancer	0.0028	0.00792	CbGpPWpGaD
Flumazenil—Chills—Doxorubicin—liver cancer	0.00278	0.0043	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—liver cancer	0.00277	0.00429	CcSEcCtD
Flumazenil—GABRA4—Transmission across Chemical Synapses—GLUL—liver cancer	0.00277	0.00784	CbGpPWpGaD
Flumazenil—Vision blurred—Epirubicin—liver cancer	0.00275	0.00425	CcSEcCtD
Flumazenil—Ill-defined disorder—Epirubicin—liver cancer	0.00271	0.00419	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—liver cancer	0.0027	0.00418	CcSEcCtD
Flumazenil—Agitation—Epirubicin—liver cancer	0.00268	0.00415	CcSEcCtD
Flumazenil—Tension—Doxorubicin—liver cancer	0.00265	0.0041	CcSEcCtD
Flumazenil—Malaise—Epirubicin—liver cancer	0.00263	0.00407	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—liver cancer	0.00262	0.00406	CcSEcCtD
Flumazenil—Vertigo—Epirubicin—liver cancer	0.00262	0.00406	CcSEcCtD
Flumazenil—Palpitations—Epirubicin—liver cancer	0.00258	0.00399	CcSEcCtD
Flumazenil—Cough—Epirubicin—liver cancer	0.00255	0.00394	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—liver cancer	0.00255	0.00394	CcSEcCtD
Flumazenil—Hypertension—Epirubicin—liver cancer	0.00252	0.0039	CcSEcCtD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00252	0.00713	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00252	0.00713	CbGpPWpGaD
Flumazenil—Ill-defined disorder—Doxorubicin—liver cancer	0.00251	0.00387	CcSEcCtD
Flumazenil—GABRA4—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00249	0.00704	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00249	0.00704	CbGpPWpGaD
Flumazenil—Chest pain—Epirubicin—liver cancer	0.00248	0.00384	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—liver cancer	0.00248	0.00384	CcSEcCtD
Flumazenil—Anxiety—Epirubicin—liver cancer	0.00248	0.00383	CcSEcCtD
Flumazenil—GABRA5—Transmission across Chemical Synapses—GLUL—liver cancer	0.00246	0.00697	CbGpPWpGaD
Flumazenil—Discomfort—Epirubicin—liver cancer	0.00246	0.0038	CcSEcCtD
Flumazenil—GABRA1—Ion channel transport—ATP7B—liver cancer	0.00245	0.00692	CbGpPWpGaD
Flumazenil—Malaise—Doxorubicin—liver cancer	0.00244	0.00377	CcSEcCtD
Flumazenil—Dry mouth—Epirubicin—liver cancer	0.00243	0.00376	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—liver cancer	0.00243	0.00375	CcSEcCtD
Flumazenil—GABRA3—Transmission across Chemical Synapses—GLUL—liver cancer	0.00242	0.00684	CbGpPWpGaD
Flumazenil—Confusional state—Epirubicin—liver cancer	0.0024	0.00371	CcSEcCtD
Flumazenil—Palpitations—Doxorubicin—liver cancer	0.00239	0.00369	CcSEcCtD
Flumazenil—GABRA2—Transmission across Chemical Synapses—GLUL—liver cancer	0.00238	0.00673	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—GLUL—liver cancer	0.00236	0.00668	CbGpPWpGaD
Flumazenil—Cough—Doxorubicin—liver cancer	0.00236	0.00364	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—liver cancer	0.00233	0.00361	CcSEcCtD
Flumazenil—GABRA6—Orphan transporters—CYCS—liver cancer	0.00233	0.00659	CbGpPWpGaD
Flumazenil—Tachycardia—Epirubicin—liver cancer	0.00232	0.0036	CcSEcCtD
Flumazenil—GABRG2—Transmission across Chemical Synapses—GLUL—liver cancer	0.00232	0.00656	CbGpPWpGaD
Flumazenil—Hyperhidrosis—Epirubicin—liver cancer	0.0023	0.00356	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—liver cancer	0.0023	0.00356	CcSEcCtD
Flumazenil—GABRA4—Orphan transporters—CYCS—liver cancer	0.0023	0.0065	CbGpPWpGaD
Flumazenil—Anxiety—Doxorubicin—liver cancer	0.00229	0.00354	CcSEcCtD
Flumazenil—Discomfort—Doxorubicin—liver cancer	0.00227	0.00351	CcSEcCtD
Flumazenil—Dry mouth—Doxorubicin—liver cancer	0.00225	0.00348	CcSEcCtD
Flumazenil—Hypotension—Epirubicin—liver cancer	0.00223	0.00344	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—liver cancer	0.00222	0.00344	CcSEcCtD
Flumazenil—GABRA5—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00221	0.00625	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00221	0.00625	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00217	0.00614	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00217	0.00614	CbGpPWpGaD
Flumazenil—Insomnia—Epirubicin—liver cancer	0.00215	0.00333	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—liver cancer	0.00215	0.00333	CcSEcCtD
Flumazenil—GABRA6—Neuronal System—GLUL—liver cancer	0.00215	0.00609	CbGpPWpGaD
Flumazenil—Paraesthesia—Epirubicin—liver cancer	0.00214	0.00331	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—ALPL—liver cancer	0.00214	0.00605	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00213	0.00603	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00213	0.00603	CbGpPWpGaD
Flumazenil—Hyperhidrosis—Doxorubicin—liver cancer	0.00213	0.00329	CcSEcCtD
Flumazenil—Dyspnoea—Epirubicin—liver cancer	0.00212	0.00328	CcSEcCtD
Flumazenil—GABRA4—Neuronal System—GLUL—liver cancer	0.00212	0.00601	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00212	0.00599	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00212	0.00599	CbGpPWpGaD
Flumazenil—Somnolence—Epirubicin—liver cancer	0.00212	0.00327	CcSEcCtD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00208	0.00589	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00208	0.00589	CbGpPWpGaD
Flumazenil—Hypotension—Doxorubicin—liver cancer	0.00206	0.00318	CcSEcCtD
Flumazenil—Fatigue—Epirubicin—liver cancer	0.00205	0.00318	CcSEcCtD
Flumazenil—GABRA5—Orphan transporters—CYCS—liver cancer	0.00204	0.00578	CbGpPWpGaD
Flumazenil—Pain—Epirubicin—liver cancer	0.00204	0.00315	CcSEcCtD
Flumazenil—GABRA1—Transmission across Chemical Synapses—GLUL—liver cancer	0.00203	0.00573	CbGpPWpGaD
Flumazenil—GABRA3—Orphan transporters—CYCS—liver cancer	0.00201	0.00568	CbGpPWpGaD
Flumazenil—Insomnia—Doxorubicin—liver cancer	0.00199	0.00308	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—liver cancer	0.00198	0.00306	CcSEcCtD
Flumazenil—GABRA2—Orphan transporters—CYCS—liver cancer	0.00197	0.00558	CbGpPWpGaD
Flumazenil—Dyspnoea—Doxorubicin—liver cancer	0.00197	0.00304	CcSEcCtD
Flumazenil—Feeling abnormal—Epirubicin—liver cancer	0.00196	0.00304	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—liver cancer	0.00196	0.00303	CcSEcCtD
Flumazenil—GABRB3—Orphan transporters—CYCS—liver cancer	0.00196	0.00554	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—CYCS—liver cancer	0.00192	0.00544	CbGpPWpGaD
Flumazenil—Fatigue—Doxorubicin—liver cancer	0.0019	0.00294	CcSEcCtD
Flumazenil—Urticaria—Epirubicin—liver cancer	0.00189	0.00293	CcSEcCtD
Flumazenil—GABRA5—Neuronal System—GLUL—liver cancer	0.00189	0.00534	CbGpPWpGaD
Flumazenil—Pain—Doxorubicin—liver cancer	0.00188	0.00291	CcSEcCtD
Flumazenil—GABRB3—BDNF signaling pathway—ADAM17—liver cancer	0.00188	0.00531	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—GLUL—liver cancer	0.00185	0.00524	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—GLUL—liver cancer	0.00182	0.00515	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00182	0.00514	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00182	0.00514	CbGpPWpGaD
Flumazenil—Feeling abnormal—Doxorubicin—liver cancer	0.00182	0.00281	CcSEcCtD
Flumazenil—GABRB3—Neuronal System—GLUL—liver cancer	0.00181	0.00512	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—GLUL—liver cancer	0.00178	0.00503	CbGpPWpGaD
Flumazenil—Hypersensitivity—Epirubicin—liver cancer	0.00176	0.00271	CcSEcCtD
Flumazenil—Urticaria—Doxorubicin—liver cancer	0.00175	0.00271	CcSEcCtD
Flumazenil—Asthenia—Epirubicin—liver cancer	0.00171	0.00264	CcSEcCtD
Flumazenil—Pruritus—Epirubicin—liver cancer	0.00169	0.00261	CcSEcCtD
Flumazenil—GABRA1—Orphan transporters—CYCS—liver cancer	0.00168	0.00476	CbGpPWpGaD
Flumazenil—GABRA6—Orphan transporters—PPARA—liver cancer	0.00163	0.00463	CbGpPWpGaD
Flumazenil—Hypersensitivity—Doxorubicin—liver cancer	0.00162	0.00251	CcSEcCtD
Flumazenil—GABRA4—Orphan transporters—PPARA—liver cancer	0.00161	0.00457	CbGpPWpGaD
Flumazenil—Asthenia—Doxorubicin—liver cancer	0.00158	0.00245	CcSEcCtD
Flumazenil—Dizziness—Epirubicin—liver cancer	0.00158	0.00244	CcSEcCtD
Flumazenil—Pruritus—Doxorubicin—liver cancer	0.00156	0.00241	CcSEcCtD
Flumazenil—GABRA1—Neuronal System—GLUL—liver cancer	0.00155	0.00439	CbGpPWpGaD
Flumazenil—Vomiting—Epirubicin—liver cancer	0.00151	0.00234	CcSEcCtD
Flumazenil—Rash—Epirubicin—liver cancer	0.0015	0.00232	CcSEcCtD
Flumazenil—Dermatitis—Epirubicin—liver cancer	0.0015	0.00232	CcSEcCtD
Flumazenil—Headache—Epirubicin—liver cancer	0.00149	0.00231	CcSEcCtD
Flumazenil—Dizziness—Doxorubicin—liver cancer	0.00146	0.00225	CcSEcCtD
Flumazenil—GABRA5—Orphan transporters—PPARA—liver cancer	0.00143	0.00406	CbGpPWpGaD
Flumazenil—Nausea—Epirubicin—liver cancer	0.00141	0.00219	CcSEcCtD
Flumazenil—GABRA3—Orphan transporters—PPARA—liver cancer	0.00141	0.00399	CbGpPWpGaD
Flumazenil—Vomiting—Doxorubicin—liver cancer	0.0014	0.00217	CcSEcCtD
Flumazenil—Rash—Doxorubicin—liver cancer	0.00139	0.00215	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—liver cancer	0.00139	0.00215	CcSEcCtD
Flumazenil—GABRA2—Orphan transporters—PPARA—liver cancer	0.00138	0.00392	CbGpPWpGaD
Flumazenil—Headache—Doxorubicin—liver cancer	0.00138	0.00214	CcSEcCtD
Flumazenil—GABRB3—Orphan transporters—PPARA—liver cancer	0.00137	0.00389	CbGpPWpGaD
Flumazenil—GABRG2—Orphan transporters—PPARA—liver cancer	0.00135	0.00382	CbGpPWpGaD
Flumazenil—Nausea—Doxorubicin—liver cancer	0.00131	0.00202	CcSEcCtD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00129	0.00365	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00127	0.0036	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00123	0.00348	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00121	0.00344	CbGpPWpGaD
Flumazenil—GABRA1—Orphan transporters—PPARA—liver cancer	0.00118	0.00334	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00118	0.00334	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00118	0.00334	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00116	0.00329	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00116	0.00329	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00113	0.0032	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00111	0.00316	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00111	0.00314	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—NR1H4—liver cancer	0.0011	0.00312	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00109	0.00309	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00108	0.00307	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00108	0.00305	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00106	0.00301	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00106	0.003	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00104	0.00295	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.00104	0.00294	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00103	0.00293	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00103	0.00293	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00103	0.00293	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.00102	0.0029	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00102	0.00287	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00102	0.00287	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00102	0.00287	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000998	0.00283	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000998	0.00283	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000992	0.00281	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000992	0.00281	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAPK14—liver cancer	0.000979	0.00277	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000978	0.00277	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000974	0.00276	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000974	0.00276	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00096	0.00272	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000944	0.00267	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000938	0.00265	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000931	0.00263	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000921	0.00261	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.00091	0.00258	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—APC—liver cancer	0.000908	0.00257	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000894	0.00253	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000888	0.00251	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000878	0.00249	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000872	0.00247	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000866	0.00245	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000857	0.00242	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000855	0.00242	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000851	0.00241	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000851	0.00241	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000805	0.00228	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—BRAF—liver cancer	0.00078	0.00221	CbGpPWpGaD
Flumazenil—GABRA6—Ion channel transport—RAF1—liver cancer	0.000771	0.00218	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—BRAF—liver cancer	0.00077	0.00218	CbGpPWpGaD
Flumazenil—GABRA4—Ion channel transport—RAF1—liver cancer	0.000761	0.00215	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.00076	0.00215	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—liver cancer	0.000749	0.00212	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000746	0.00211	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000733	0.00208	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000728	0.00206	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000715	0.00202	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—RAF1—liver cancer	0.000712	0.00202	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MTOR—liver cancer	0.000695	0.00197	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—BRAF—liver cancer	0.000684	0.00194	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—RAF1—liver cancer	0.000676	0.00191	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—BRAF—liver cancer	0.000672	0.0019	CbGpPWpGaD
Flumazenil—GABRA3—Ion channel transport—RAF1—liver cancer	0.000664	0.00188	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—BRAF—liver cancer	0.00066	0.00187	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—BRAF—liver cancer	0.000656	0.00186	CbGpPWpGaD
Flumazenil—GABRA2—Ion channel transport—RAF1—liver cancer	0.000652	0.00185	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—RAF1—liver cancer	0.000651	0.00184	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—RAF1—liver cancer	0.000648	0.00183	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—BRAF—liver cancer	0.000644	0.00182	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—RAF1—liver cancer	0.000643	0.00182	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CASP3—liver cancer	0.00064	0.00181	CbGpPWpGaD
Flumazenil—GABRG2—Ion channel transport—RAF1—liver cancer	0.000637	0.0018	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—liver cancer	0.000625	0.00177	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—JUN—liver cancer	0.000621	0.00176	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—CTNNB1—liver cancer	0.000617	0.00174	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—BRAF—liver cancer	0.000597	0.00169	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—BRAF—liver cancer	0.00059	0.00167	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—MAPK8—liver cancer	0.000588	0.00166	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—RAF1—liver cancer	0.000571	0.00162	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—CYCS—liver cancer	0.000568	0.00161	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000563	0.00159	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—CYCS—liver cancer	0.000561	0.00159	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000561	0.00159	CbGpPWpGaD
Flumazenil—GABRA1—Ion channel transport—RAF1—liver cancer	0.000556	0.00157	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000551	0.00156	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—RAF1—liver cancer	0.000548	0.00155	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—RAF1—liver cancer	0.000538	0.00152	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—STAT3—liver cancer	0.000537	0.00152	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—BRAF—liver cancer	0.000524	0.00148	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000515	0.00146	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—BRAF—liver cancer	0.000515	0.00146	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—BRAF—liver cancer	0.000506	0.00143	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—BRAF—liver cancer	0.000503	0.00142	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—JUN—liver cancer	0.0005	0.00142	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—RAF1—liver cancer	0.000499	0.00141	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—CYCS—liver cancer	0.000499	0.00141	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000496	0.0014	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000494	0.0014	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—BRAF—liver cancer	0.000493	0.0014	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—RAF1—liver cancer	0.000493	0.00139	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—CYCS—liver cancer	0.00049	0.00139	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000488	0.00138	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000481	0.00136	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000478	0.00135	CbGpPWpGaD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000477	0.00135	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000471	0.00133	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—RAF1—liver cancer	0.00047	0.00133	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000469	0.00133	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—RAF1—liver cancer	0.000438	0.00124	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000437	0.00124	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000433	0.00123	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—BRAF—liver cancer	0.000431	0.00122	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—RAF1—liver cancer	0.00043	0.00122	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000426	0.0012	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—RAF1—liver cancer	0.000422	0.0012	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—RAF1—liver cancer	0.00042	0.00119	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000418	0.00118	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000418	0.00118	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000415	0.00118	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—RAF1—liver cancer	0.000412	0.00117	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000411	0.00116	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—CYCS—liver cancer	0.00041	0.00116	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000408	0.00115	CbGpPWpGaD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000404	0.00114	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000401	0.00114	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—PPARA—liver cancer	0.000399	0.00113	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—PPARA—liver cancer	0.000394	0.00112	CbGpPWpGaD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000394	0.00111	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—HRAS—liver cancer	0.000392	0.00111	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000374	0.00106	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—RAF1—liver cancer	0.00036	0.00102	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—HRAS—liver cancer	0.000359	0.00101	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000357	0.00101	CbGpPWpGaD
Flumazenil—GABRA4—Transmission across Chemical Synapses—HRAS—liver cancer	0.000354	0.001	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—PPARA—liver cancer	0.00035	0.000991	CbGpPWpGaD
Flumazenil—GABRB3—BDNF signaling pathway—AKT1—liver cancer	0.000346	0.00098	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000344	0.000975	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000344	0.000973	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000338	0.000956	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000336	0.00095	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	0.00033	0.000933	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—HRAS—liver cancer	0.000315	0.00089	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000309	0.000874	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000304	0.000859	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000302	0.000855	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—HRAS—liver cancer	0.000302	0.000854	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ALB—liver cancer	0.000297	0.000839	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000296	0.000838	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ALB—liver cancer	0.000293	0.000829	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000288	0.000815	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—HRAS—liver cancer	0.000275	0.000777	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—HRAS—liver cancer	0.000271	0.000768	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—RAF1—liver cancer	0.000268	0.000759	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—RAF1—liver cancer	0.000265	0.00075	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ALB—liver cancer	0.00026	0.000736	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	0.000259	0.000733	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ALB—liver cancer	0.000256	0.000723	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	0.000251	0.000711	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ALB—liver cancer	0.000249	0.000706	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	0.000245	0.000693	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—HRAS—liver cancer	0.000241	0.000682	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—HRAS—liver cancer	0.000237	0.00067	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—RAF1—liver cancer	0.000235	0.000666	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—HRAS—liver cancer	0.000233	0.000658	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000231	0.000654	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—HRAS—liver cancer	0.000231	0.000654	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000227	0.000643	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—HRAS—liver cancer	0.000227	0.000642	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000226	0.000639	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000222	0.000627	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	0.000214	0.000606	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—HRAS—liver cancer	0.000198	0.000561	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000194	0.000548	CbGpPWpGaD
